Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
about
A basal ganglia pathway drives selective auditory responses in songbird dopaminergic neurons via disinhibition.Dopamine responsiveness is regulated by targeted sorting of D2 receptors.The neurobiology and genetics of impulse control disorders: relationships to drug addictionsKappa opioids as potential treatments for stimulant dependenceDynorphin, stress, and depressionKappa-opioid ligands in the study and treatment of mood disordersPharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependenceSex Differences in Kappa Opioid Receptor Function and Their Potential Impact on AddictionEstablishing causality for dopamine in neural function and behavior with optogeneticsRole of kappa-opioid receptors in stress and anxiety-related behavior.Drug withdrawal conceptualized as a stressor.Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in HumansEthanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs.A Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid SystemKappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine NeuronsCorticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neuronsStress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticityKappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence30 years of dynorphins--new insights on their functions in neuropsychiatric diseasesActivation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area.Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress.Translational studies of alcoholism: bridging the gap.Reliability in the identification of midbrain dopamine neurons.The role of cannabinoid transmission in emotional memory formation: implications for addiction and schizophreniaThe role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuseNeurobiology of dysregulated motivational systems in drug addiction.Methamphetamine-induced stereotypy correlates negatively with patch-enhanced prodynorphin and arc mRNA expression in the rat caudate putamen: the role of mu opioid receptor activation.Ethanol blocks long-term potentiation of GABAergic synapses in the ventral tegmental area involving mu-opioid receptors.How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.The role of kappa-opioid receptor activation in mediating antinociception and addiction.Acupuncture inhibits GABA neuron activity in the ventral tegmental area and reduces ethanol self-administrationIdentification of rat ventral tegmental area GABAergic neurons.New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system.Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.Direct bidirectional μ-opioid control of midbrain dopamine neuronsGABAergic transmission modulates ethanol excitation of ventral tegmental area dopamine neuronsKappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortexKappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.
P2860
Q22255502-9C004A91-38B8-4CB5-A54F-96740EA379A8Q24534573-69AD725B-3D04-4013-A4DC-CD6AE07E4E4EQ24642641-533DA522-9ECD-406D-901C-BE8928FE5B29Q24647849-28F18A27-45C8-4447-AE7D-BF74A03F5967Q24650168-680B7CFF-EBA9-45D1-BA4E-AD7667C8863DQ24657982-F39808EB-A4C2-4D7E-AB4C-3607CF385628Q24658266-6533EA48-A92A-46EC-BA2E-C98392F3CC17Q26770785-BDF03908-5E6C-4F1D-A974-CA2D19720160Q26864879-5EC86AB3-5F93-4DC1-8E8E-43EACC027131Q26991739-8008C657-8FA3-4FB0-8C8F-B4F4BF75D9E9Q26997989-20F638AE-B2D9-4259-8A99-6CBA09E673E7Q27300685-8ED6E2D6-A20A-4930-A5C4-32D484F24782Q27687624-CB366DEA-24D9-4E01-A730-FEB8DEF88870Q28074686-E65CFCDF-2FFE-446D-AAC7-6378FCC952DBQ28267475-A8FD9653-48CF-41F5-9DE3-543BD2791022Q28568495-DDF1F522-B3CA-426D-AED5-E6D7D8A72085Q30366964-C4C18F7C-7593-4CFB-AB24-0EE39FC8AB2DQ30435816-CC23227E-ECD1-4D54-BEC8-FA3D7A5380D3Q30453617-F528BF5F-53BC-4246-8A21-CCBC66A9CEEFQ30481450-C4F98140-000A-4E24-90ED-1C39F5C2753CQ30491620-8A731BE5-A537-4F9C-9C7D-A4A07E7713ACQ30497524-92CFE0C2-BE33-4ACC-AA5A-AC2039365255Q33558914-774F20AC-7253-40C9-8E63-A0D5431F25D2Q33559892-ED8FEE76-41B7-4102-AE9D-C9D1C6CC05C1Q33769135-F194647A-D65A-489E-A3BE-36FE0A153C76Q33820114-2EB19D95-734B-4589-A1F5-981D0EDCDE3DQ33890721-F039F1AF-6CD1-48B4-A85F-65885B936EFDQ33915824-92813385-98A8-4382-A1CA-5487D285A59AQ33943736-FBBFF9A5-9D89-4D73-9FE2-7EF11231D84AQ33998572-B546DB18-71DB-4C82-823E-D8EE1A1E51DBQ34073903-A99AEF2D-C58C-47C9-8329-1310E7B340EFQ34132638-A3BC79BA-FB29-4AD4-A706-F4135A4533F7Q34336561-9F9BE009-2B25-47A2-867A-6D4F3982D583Q34364830-4EA97101-0C86-40A9-ACCB-3A92B2CE2F68Q34383064-4FF65632-50DA-44D7-AB68-2A85B69643EBQ34401390-66C64611-07FA-474E-B8A0-624A6E682664Q34416532-6965A59D-04C0-47C4-8C4D-980CFA0AC834Q34441592-B4980111-EB22-48B4-8218-37393353AF8AQ34479813-E34330D1-4D8E-4C52-B654-C3C48A496E87Q34499320-579E16CC-BF88-4910-AF6C-47EB510CE5B4
P2860
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
@en
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
@nl
type
label
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
@en
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
@nl
prefLabel
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
@en
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
@nl
P2093
P1476
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons
@en
P2093
Antonello Bonci
Elyssa B Margolis
Gregory O Hjelmstad
Howard L Fields
P304
P356
10.1523/JNEUROSCI.23-31-09981.2003
P407
P577
2003-11-01T00:00:00Z